The Burden of Informal Caregiving for Adults with Musculoskeletal Conditions: A Systematic Review

Nanati Legese, Neha Das, Jennifer J Watts, Suzanne Robinson, Gang Chen, Lan GaoPharmacoEconomics 2025 · DOI

Abstract

This systematic review highlights the considerable psychological, economic, and time-related burdens faced by informal caregivers of individuals with musculoskeletal conditions. Caregivers face high stress, physical strain, and opportunity costs. The lack of standardized assessments hinders accurate burden quantification, economic evaluation, and policy responses. Future efforts should focus on adopting consistent measurement instruments and valuation methods, alongside implementing structured policies, financial support, and psychological interventions to better support the caregivers.

Introduction: The "Shadow" Burden of MSCs

Musculoskeletal conditions (MSCs)—including rheumatoid arthritis, osteoarthritis, and spinal cord injuries—are the leading cause of global disability, affecting over 1.7 billion people. While clinical research often focuses on patient outcomes, the "shadow" burden borne by informal caregivers (unpaid family and friends) remains under-quantified. Unlike the cognitive supervision required for conditions like dementia, MSC caregiving involves intense physical assistance with mobility and pain management, alongside instrumental support for daily living. This review synthesizes the psychological strain, time-related pressures, and economic impacts faced by this specific population.

Methodology

The authors conducted a systematic review following PRISMA guidelines, searching five major databases (MEDLINE, Embase, CINAHL, PsycINFO, and EconLIT) for studies published between 2000 and April 2025.

PRISMA Flow Diagram of the study selection process.

Methodological rigor was ensured through:

  • Risk of Bias Assessment: Utilizing the CASP checklist for psychological studies and EVERS criteria for economic evaluations.
  • Economic Standardization: All reported costs were adjusted to 2023 US Dollars using Purchasing Power Parity (PPP) conversion rates to allow for cross-country and cross-temporal comparisons.
  • Synthesis: A narrative synthesis was used for heterogeneous outcomes, while a random-effects model meta-analysis was applied to a subset of studies reporting informal care hours.

Study Characteristics and Datasets

The review included 41 peer-reviewed studies across 18 countries. The dataset is categorized into two primary domains:

  1. Psychological Burden (25 studies): Utilizing tools such as the Zarit Burden Interview (ZBI) and Caregiver Strain Index (CSI).
  2. Economic Burden (16 studies): Employing Cost-of-Illness (COI) or Cost-Utility frameworks.
Summary of study characteristics focusing on psychological burden and MSC types.

The conditions covered spanned a wide range, with rheumatoid arthritis being the most frequently studied, followed by spinal cord injuries, osteoarthritis, and osteoporosis.

Key Insights

The Time-Dependence Trap

Across multiple assessment scales, "time-dependence burden" emerged as the most prominent challenge. Caregiving for MSCs is characterized by prolonged, daily disruption of schedules over many years, rather than just episodic intensity.

Valuation Disparity in Economics

The economic value of care varies significantly based on the valuation method. The Replacement Cost method (market rate for professional care) generally yielded higher estimates than the Opportunity Cost method (caregiver's lost wages).

The Spillover and Physical Toll

Caregiver well-being was found to be significantly correlated with patient well-being. Interventions improving patient pain management often resulted in a "double win," indirectly boosting caregiver mental health. Notably, MSC caregivers reported high levels of their own physical pain, likely due to the manual labor involved in mobility assistance.

Key Results

  • Care Hours: Meta-analysis revealed that caregivers spend an average of 58.4 hours per week (95% CI 21.08–95.82) providing support.
  • Economic Impact: Informal care costs accounted for 30% to 54% of total illness costs in COI studies. In extreme cases, such as fibromyalgia in Spain, annual informal care costs reached $74,607 (USD 2023).
  • Psychological Health: Caregivers consistently scored lower on Mental Component Summary (MCS) scores than the general population (e.g., 36.35 vs. 50 in an Australian cohort).
  • Unit Costs: Estimated "shadow" wages ranged from $10.50/hour** (Canada) to **$64.25/hour (Netherlands).

Limitations and Future Directions

The field faces several hurdles:

  • Methodological Fragmentation: A lack of standardized tools makes cross-disease comparisons difficult.
  • Data Gaps: There is a shortage of longitudinal data tracking how burden evolves as conditions progress.
  • Language Bias: The review was limited to English-language publications.

Future research should adopt preference-based methods (e.g., discrete choice experiments) to capture the subjective value caregivers place on their time. Policy reforms, including financial compensation and structured respite care, are essential to mitigate this massive, often invisible, societal burden.

Summary updated

Abstract

This systematic review highlights the considerable psychological, economic, and time-related burdens faced by informal caregivers of individuals with musculoskeletal conditions. Caregivers face high stress, physical strain, and opportunity costs. The lack of standardized assessments hinders accurate burden quantification, economic evaluation, and policy responses. Future efforts should focus on adopting consistent measurement instruments and valuation methods, alongside implementing structured policies, financial support, and psychological interventions to better support the caregivers.
BibTeX
@inproceedings{legese2025burden,
  author = {Nanati Legese and Neha Das and Jennifer J Watts and Suzanne Robinson and Gang Chen and Lan Gao},
  title = {{The Burden of Informal Caregiving for Adults with Musculoskeletal Conditions: A Systematic Review}},
  booktitle = {PharmacoEconomics},
  year = {2025},
  doi = {10.1007/s40273-025-01523-x},
}
Figure